摘要 |
Methods and apparatus for identifying disease status according to various aspects of the present invention include delivering one or more imaging agents to all or parts of the body for disease observation, screening and/or detection. The methods and apparatus may deliver imaging agents that include any suitable disease-associated compositions, such as riboflavin carrier protein (RCP) and/or RCP modifications and antibodies thereof, labeled with an imaging label. In one embodiment, the imaging agents may be delivered to a selected site or sites in the body and subsequently observed using an imaging method. In another embodiment, the imaging agents may be delivered throughout the body for screening applications. In yet another embodiment, the imaging agents may be delivered throughout the body to detect a reduction and/or increase in cellular metabolism.
|